Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma
Clinical trial NCT04602078 · COMPLETED
Trial details
- NCT number
- NCT04602078
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2024-02-02
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.